Advertisement
Screener

Exelixis Inc (EXEL) Diluted Shares Outstanding (Weighted Average)

Exelixis Inc Diluted Shares Outstanding (Weighted Average)

Exelixis Inc (EXEL) reported Diluted Shares Outstanding (Weighted Average) of 259.68 million shares for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-05

  • Exelixis Inc weighted average number of shares outstanding, diluted for the quarter ending 2026-07-03 was 259.68M shares, a 8.69% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, diluted for the quarter ending 2026-04-03 was 267.32M shares, a 7.24% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, diluted for the quarter ending 2026-01-02 was 276.35M shares, a 5.86% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, diluted for the quarter ending 2025-10-03 was 278.54M shares, a 4.44% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, diluted for fiscal 2026 was 281.86M shares, a 4.82% decline from fiscal 2025.
  • Exelixis Inc weighted average number of shares outstanding, diluted for fiscal 2025 was 296.13M shares, a 7.88% decline from fiscal 2023.
  • Exelixis Inc weighted average number of shares outstanding, diluted for fiscal 2023 was 321.46M shares, a 0.95% decline from fiscal 2022.
  • Exelixis Inc weighted average number of shares outstanding, diluted for fiscal 2022 was 324.56M shares, a 0.68% increase from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Diluted 3 monthWeighted Average Number of Shares Outstanding, Diluted 3 month as first filedWeighted Average Number of Shares Outstanding, Diluted 6 monthWeighted Average Number of Shares Outstanding, Diluted 9 monthWeighted Average Number of Shares Outstanding, Diluted 9 month as first filedWeighted Average Number of Shares Outstanding, Diluted 12 month
2026-07-03259.68M shares
10-Q · filed 2026-08-05
263.50M shares
10-Q · filed 2026-08-05
267.78M shares
derived: average of 3 quarters · filed 2026-08-05
270.47M shares
derived: average of 4 quarters · filed 2026-08-05
2026-04-03267.32M shares
10-Q · filed 2026-05-05
271.84M shares
derived: average of 2 quarters · filed 2026-05-05
274.07M shares
derived: average of 3 quarters · filed 2026-05-05
276.65M shares
derived: average of 4 quarters · filed 2026-08-05
2026-01-02276.35M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
277.44M shares
derived: average of 2 quarters · filed 2026-02-10
279.76M shares
derived: average of 3 quarters · filed 2026-08-05
281.86M shares
10-K · filed 2026-02-10
2025-10-03278.54M shares
10-Q · filed 2025-11-04
281.46M shares
derived: average of 2 quarters · filed 2026-08-05
283.70M shares
10-Q · filed 2025-11-04
286.16M shares
derived: average of 4 quarters · filed 2026-08-05
2025-07-04284.39M shares
10-Q · filed 2026-08-05
286.29M shares
10-Q · filed 2026-08-05
288.71M shares
derived: average of 3 quarters · filed 2026-08-05
289.40M shares
derived: average of 4 quarters · filed 2026-08-05
2025-04-04288.18M shares
10-Q · filed 2026-05-05
290.86M shares
derived: average of 2 quarters · filed 2026-05-05
291.07M shares
derived: average of 3 quarters · filed 2026-05-05
291.79M shares
derived: average of 4 quarters · filed 2026-05-05
2025-01-03293.55M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
292.51M shares
derived: average of 2 quarters · filed 2026-02-10
293.00M shares
derived: average of 3 quarters · filed 2026-02-10
296.13M shares
10-K · filed 2026-02-10
2024-09-27291.48M shares
10-Q · filed 2025-11-04
292.73M shares
derived: average of 2 quarters · filed 2025-11-04
296.99M shares
10-Q · filed 2025-11-04
301.00M shares
derived: average of 4 quarters · filed 2026-02-10
2024-06-28293.97M shares
10-Q · filed 2025-07-28
299.75M shares
10-Q · filed 2025-07-28
304.18M shares
derived: average of 3 quarters · filed 2026-02-10
307.94M shares
derived: average of 4 quarters · filed 2026-02-10
2024-03-29305.53M shares
10-Q · filed 2025-05-13
309.28M shares
derived: average of 2 quarters · filed 2026-02-10
312.60M shares
derived: average of 3 quarters · filed 2026-02-10
316.28M shares
derived: average of 4 quarters · filed 2026-02-10
2023-12-29313.02M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
316.14M shares
derived: average of 2 quarters · filed 2026-02-10
319.86M shares
derived: average of 3 quarters · filed 2026-02-10
321.46M shares
10-K · filed 2026-02-10
2023-09-29319.25M shares
10-Q · filed 2024-10-29
323.28M shares
derived: average of 2 quarters · filed 2024-10-29
324.28M shares
10-Q · filed 2024-10-29
324.45M shares
derived: average of 4 quarters · filed 2025-02-11
2023-06-30327.31M shares
10-Q · filed 2024-08-06
326.79M shares
10-Q · filed 2024-08-06
326.18M shares
derived: average of 3 quarters · filed 2025-02-11
325.90M shares
derived: average of 4 quarters · filed 2025-02-11
2023-03-31326.28M shares
10-Q · filed 2024-04-30
325.62M shares
derived: average of 2 quarters · filed 2025-02-11
325.44M shares
derived: average of 3 quarters · filed 2025-02-11
325.30M shares
derived: average of 4 quarters · filed 2025-02-11
2022-12-30324.96M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11
325.01M shares
derived: average of 2 quarters · filed 2025-02-11
324.98M shares
derived: average of 3 quarters · filed 2025-02-11
324.56M shares
10-K · filed 2025-02-11
2022-09-30325.07M shares
10-Q · filed 2023-11-01
324.99M shares
derived: average of 2 quarters · filed 2023-11-01
324.42M shares
10-Q · filed 2023-11-01
324.11M shares
derived: average of 4 quarters · filed 2024-02-06
2022-07-01324.90M shares
10-Q · filed 2023-08-01
324.10M shares
10-Q · filed 2023-08-01
323.79M shares
derived: average of 3 quarters · filed 2024-02-06
323.35M shares
derived: average of 4 quarters · filed 2024-02-06
2022-04-01323.29M shares
10-Q · filed 2023-05-09
323.24M shares
derived: average of 2 quarters · filed 2024-02-06
322.83M shares
derived: average of 3 quarters · filed 2024-02-06
322.86M shares
derived: average of 4 quarters · filed 2024-02-06
2021-12-31323.18M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-06
322.60M shares
derived: average of 2 quarters · filed 2024-02-06
322.72M shares
derived: average of 3 quarters · filed 2024-02-06
322.36M shares
10-K · filed 2024-02-06
2021-10-01322.02M shares
10-Q · filed 2022-11-01
322.48M shares
derived: average of 2 quarters · filed 2022-11-01
322.08M shares
10-Q · filed 2022-11-01
321.44M shares
derived: average of 4 quarters · filed 2023-02-07
2021-07-02322.94M shares
10-Q · filed 2022-08-09
322.11M shares
10-Q · filed 2022-08-09
321.25M shares
derived: average of 3 quarters · filed 2023-02-07
318.22M shares
derived: average of 4 quarters · filed 2023-02-07
2021-04-02321.29M shares
10-Q · filed 2022-05-10
320.40M shares
derived: average of 2 quarters · filed 2023-02-07
316.64M shares
derived: average of 3 quarters · filed 2023-02-07
317.02M shares
derived: average of 4 quarters · filed 2023-02-07
2021-01-01319.52M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07
314.32M shares
derived: average of 2 quarters · filed 2023-02-07
315.59M shares
derived: average of 3 quarters · filed 2023-02-07
318.00M shares
10-K · filed 2023-02-07
2020-10-02309.12M shares
10-Q · filed 2021-11-02
313.63M shares
derived: average of 2 quarters · filed 2021-11-02
317.50M shares
10-Q · filed 2021-11-02
314.50M shares
derived: average of 4 quarters · filed 2022-02-18
2020-07-03318.14M shares
10-Q · filed 2021-08-05
316.99M shares
10-Q · filed 2021-08-05
316.29M shares
derived: average of 3 quarters · filed 2022-02-18
316.08M shares
derived: average of 4 quarters · filed 2022-02-18
2020-04-03315.84M shares
10-Q · filed 2021-05-06
315.37M shares
derived: average of 2 quarters · filed 2022-02-18
315.40M shares
derived: average of 3 quarters · filed 2022-02-18
315.28M shares
derived: average of 4 quarters · filed 2022-02-18
2020-01-03314.90M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18
315.18M shares
derived: average of 2 quarters · filed 2022-02-18
315.09M shares
derived: average of 3 quarters · filed 2022-02-18
315.01M shares
10-K · filed 2022-02-18
2019-09-27315.45M shares
10-Q · filed 2020-11-05
315.18M shares
derived: average of 2 quarters · filed 2020-11-05
315.05M shares
10-Q · filed 2020-11-05
314.15M shares
derived: average of 4 quarters · filed 2020-11-05
2019-06-28314.91M shares
10-Q · filed 2020-08-06
314.79M shares
10-Q · filed 2020-08-06
313.72M shares
derived: average of 3 quarters · filed 2020-08-06
313.38M shares
derived: average of 4 quarters · filed 2020-08-06
2019-03-29314.64M shares
10-Q · filed 2020-05-05
313.13M shares
derived: average of 2 quarters · filed 2020-05-05
312.87M shares
derived: average of 3 quarters · filed 2020-05-05
312.71M shares
derived: average of 4 quarters · filed 2020-05-05
2018-12-28311.61M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
311.98M shares
derived: average of 2 quarters · filed 2020-02-25
312.07M shares
derived: average of 3 quarters · filed 2020-02-25
312.80M shares
10-K · filed 2021-02-11
2018-09-28312.35M shares
10-Q · filed 2019-10-30
312.29M shares
derived: average of 2 quarters · filed 2019-10-30
313.20M shares
10-Q · filed 2019-10-30
312.91M shares
derived: average of 4 quarters · filed 2020-02-25
2018-06-29312.24M shares
10-Q · filed 2019-07-31
313.02M shares
10-Q · filed 2019-07-31
313.09M shares
derived: average of 3 quarters · filed 2020-02-25
313.05M shares
derived: average of 4 quarters · filed 2020-02-25
2018-03-30313.69M shares
10-Q · filed 2019-05-01
313.52M shares
derived: average of 2 quarters · filed 2020-02-25
313.33M shares
derived: average of 3 quarters · filed 2020-02-25
2017-12-29313.35M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
313.14M shares
derived: average of 2 quarters · filed 2020-02-25
312.00M shares
10-K · filed 2020-02-25
2017-09-30312.94M shares
10-Q · filed 2017-11-01
311.56M shares
10-Q · filed 2017-11-01
2017-09-29312.94M shares
10-Q · filed 2018-11-01
312.08M shares
derived: average of 2 quarters · filed 2018-11-01
311.56M shares
10-Q · filed 2018-11-01
2017-06-30311.22M shares
10-Q · filed 2018-08-01
310.76M shares
10-Q · filed 2017-08-02
2017-03-31309.54M shares
10-Q · filed 2017-05-01
2016-12-30250.53M shares
10-K · filed 2019-02-22
2016-09-30256.32M shares
10-Q · filed 2017-11-01
242.81M shares
derived: average of 2 quarters · filed 2017-11-01
238.02M shares
10-Q · filed 2017-11-01
2016-06-30229.31M shares
10-Q · filed 2017-08-02
228.86M shares
10-Q · filed 2017-08-02
2016-03-31228.30M shares
10-Q · filed 2017-05-01
2016-01-01209.23M shares
10-K · filed 2018-02-26
2013-12-31184.06M shares
10-K · filed 2014-02-20
2012-12-31183.60M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20
174.98M shares
derived: average of 2 quarters · filed 2014-02-20
160.14M shares
10-K · filed 2014-02-20
2012-09-30166.35M shares
10-Q · filed 2012-11-07
152.32M shares
10-Q · filed 2012-11-07
2011-12-31133.63M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20
132.49M shares
derived: average of 2 quarters · filed 2014-02-20
130.48M shares
10-K · filed 2014-02-20
2011-09-30131.34M shares
10-Q · filed 2012-11-07
131.34K shares
10-Q · filed 2011-10-27
129.43M shares
10-Q · filed 2012-11-07
129.43K shares
10-Q · filed 2011-10-27
2010-12-31433.76M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21
216.94M shares
derived: average of 2 quarters · filed 2013-02-21
108.52M shares
10-K · filed 2013-02-21
2010-09-30108.67K shares
10-Q · filed 2011-10-27
108.37K shares
10-Q · filed 2011-10-27
2009-12-31107.07M shares
10-K · filed 2012-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78